Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab) (CAT#: CROSSAB-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab) is designed to to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (CrossMab) (CROSSAB-019). Click the button below to contact us or submit your feedback about this product.